ProMark Proteomic Prognostic Test

**Semantic type:** Laboratory Procedure

**Definition:** A proprietary tissue-based test that uses multiplex immunofluorescent staining with monoclonal antibodies to provide a personalized prediction for prostate cancer aggressiveness. It detects an 8-protein signature (DERL1, CUL2, SMAD4, PDSS2, HSPA9, FUS, pS6 (phosphorylated S6), YBOX1).

**Synonyms:** - ProMark - ProMark Proteomic Prognostic Test for Prostate Cancer - Promark